ADAC HealthCare Information Systems (HCIS) moved to strengthen its burgeoning PACS efforts this month by signing an agreement with global information technology services firm Perot Systems. The multiyear deal stipulates that Dallas-based Perot will
ADAC HealthCare Information Systems (HCIS) moved to strengthen its burgeoning PACS efforts this month by signing an agreement with global information technology services firm Perot Systems. The multiyear deal stipulates that Dallas-based Perot will provide ADAC HCIS of Houston with professional and implementation services for ADACs QuadRIS radiology information system and Envoi PACS products. Perot will furnish ADAC clients with system integration, network design, clinical process reengineering, and Web technology support.
Introduced at 1998s RSNA meeting, Envoi is based on QuadRIS, and allows physicians to distribute images and data using Web-based technology (SCAN 1/20/99). Envoi also includes Physicians Desktop, Intranet Image Server, DICOM Acquisition, VR SoftView diagnostic and clinical review workstations, VR SoftStore and HardStore archive, and Workflow Manager. The products architecture combines Oracles relational database technology and Windows client/server software.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.